As a recognized leader in the CRO industry for conducting complex central nervous system (CNS) trials, PharPoint Research has contributed expert services critical to the approval of many important central nervous system (CNS) drugs. PharPoint Research has participated in 94 central nervous system (CNS) studies in every phase and many indications, including fever, insomnia, multiple sclerosis, Parkinson’s disease, schizophrenia, smoking cessation, Duchenne muscular dystrophy, and pain. Our significant central nervous system (CNS) therapeutic experience encompasses 27 central nervous system indications. We have provided biostatistics and data management services for dozens of these central nervous system trials. PharPoint is a full service CRO that provides support for clinical trials at every level and phase. Our network of best in class expertise allows us to provide an accomplished service for central nervous system studies of all types.
About the Author
Expanded Consulting Services
We recently expanded our consulting services in response to a growing need from clients. Read the full release here.